Kleidox Therapeutics Ltd
- Company number
- 12998606
- Status
- Active - Proposal To Strike Off
- Type
- Private Limited Company
- Incorporated
- 5 Nov 2020
- Nature of business
- Research and experimental development on biotechnology
- Corporate group
- Amgen UK Holdings Limited (3 companies)
Registered office
Officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| ABBERLEY, Russell James | Director | 30 Dec 2025 | |
| WALKER, Christopher Paul | Director | 30 Dec 2025 | 3 Jul 2026 |
| MACKINNON, Alastair Graham | Director | 9 Feb 2024 | 30 Dec 2025 |
| SMITH, Emma | Director | 9 Feb 2024 | 30 Dec 2025 |
| HANKE, Thomas, Dr | Director | 18 Jun 2022 | 9 Feb 2024 |
| DIXON-CLEGG, Nicholas George | Director | 18 Jun 2022 | 9 Feb 2024 |
| STEPHENS, Benedict Charles | Director | 21 May 2021 | 18 Jun 2022 |
| TAKENOSHITA, Takashi | Director | 5 Nov 2020 | 18 Jun 2022 |
| GULLEROVA, Monika, Dr | Director | 18 Dec 2020 | 31 Dec 2021 |
| SMITH, Emma | Director | 5 Nov 2020 | 21 May 2021 |
Control
| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Dark Blue Therapeutics Ltd | Ownership Of Shares 75 To 100 Percent Voting Rights 75 To 100 Percent Right To Appoint And Remove Directors |
5 Nov 2020 |
Accounts
| Year ended | Net assets | Employees |
|---|---|---|
| 30 Jun 2025 Dormant | £1 | 0 |
| 30 Jun 2024 Dormant | £1 | 0 |
| 30 Jun 2023 | £1 | 0 |
| 30 Jun 2022 | £1 | 1 |
| 30 Jun 2021 | £1 | 1 |
Connections
Owned by
Kleidox Therapeutics Ltd → Dark Blue Therapeutics Ltd → Amgen UK Holdings Limited
Directors’ other companies
- ABBERLEY, Russell James - Director at Amgen Limited
Companies at the same address
- Sandymount Therapeutics Ltd (13514842)